About this Research Topic
The current pandemic has stimulated an unprecedented engineering response across all domains of healthcare infrastructure, logistics, personal protective equipment, medical and digital technology, diagnostics, testing, monitoring, infrastructure, logistics, prevention, vaccine bio-processing, and therapeutics. Within this, engineers who work as the interface of physiology, pathology and treatment have come to the fore. They have devised new technologies, established fast routes for translation, and have demonstrably had significant clinical impact. This new frontier for healthcare technology will potentially set new research pathways for the role of bioengineering in future global infectious diseases.
The goal of this Research Topic is to identify the advances that are required to address future respiratory pandemics through capturing the major achievements of bio-engineers in this COVID-19 pandemic.
The editors are soliciting papers from those who have utilised bioengineering, medical engineering and biomedical engineering to address the SARS-CoV-2 and COVID-19 pandemic and those who have translated these ideas towards patients during the pandemic and with a view to the future.
The topics to be covered include (not exclusively): ventilators, rapid diagnostics, personal protective equipment, CPAPs, automating testing, big data and analytics, and computer software.
This Research Topic is in collaboration with the Association of Biomedical Engineers, Medical Engineers and Bioengineers (BioMedEng Association) and welcomes submissions from participants at their recent panel meeting as well as the community at large.
Keywords: SARS-CoV-2, COVID-19, bioengineering, biomedical engineering, medical engineering
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.